Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FK-506 tacrolimus: Phase II

Sucampo began a U.S. Phase II trial of FK-506 in 160 patients.

Read the full 125 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE